Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-11 08:19 am Sale | 2024-03-08 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 4,963,736 9.080% | -480,692 (-8.83%) | Filing History |
| 2024-03-07 12:29 pm Purchase | 2024-02-29 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 2,455,653 4.500% | 271,095 (+12.41%) | Filing History |
| 2024-02-14 3:48 pm Purchase | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 3,633,965 9.900% | 1,732,568 (+91.12%) | Filing History |
| 2024-02-14 3:00 pm Sale | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management LP | 0 0.000% | -1,650,000 (Position Closed) | Filing History |
| 2024-02-14 08:36 am Sale | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Capital LP | 0 0.000% | -1,816,531 (Position Closed) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 2,482,727 4.500% | 801,528 (+47.68%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Astria Therapeutics, Inc. ATXS | VANGUARD GROUP INC | 2,055,707 5.660% | 2,055,707 (New Position) | Filing History |
| 2024-02-12 4:17 pm Purchase | 2024-02-01 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT L.P. | 4,413,150 8.100% | 4,413,150 (New Position) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 5,444,428 14.999% | 2,092,124 (+62.41%) | Filing History |
| 2024-02-05 4:14 pm Purchase | 2024-02-01 | 13D | Astria Therapeutics, Inc. ATXS | PERCEPTIVE ADVISORS LLC | 6,485,420 11.900% | 2,857,727 (+78.78%) | Filing History |
| 2024-01-29 5:26 pm Purchase | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 2,184,558 6.000% | 2,131,485 (+4016.14%) | Filing History |
| 2024-01-16 4:18 pm Purchase | 2024-01-05 | 13G | Astria Therapeutics, Inc. ATXS | TCG Crossover GP II LLC | 4,368,928 9.900% | 4,368,928 (New Position) | Filing History |
| 2024-01-02 4:16 pm Purchase | 2023-12-21 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III L.P. | 3,225,806 8.900% | 3,225,806 (New Position) | Filing History |
| 2023-10-18 4:11 pm Purchase | 2023-10-16 | 13D | Astria Therapeutics, Inc. ATXS | PERCEPTIVE ADVISORS LLC | 3,627,693 9.900% | 1,139,891 (+45.82%) | Filing History |
| 2023-02-14 3:59 pm Unchanged | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Altium Capital Management LP | 1,355,372 4.950% | 0 (Unchanged) | Filing History |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 1,901,397 6.900% | 989,661 (+108.55%) | Filing History |
| 2023-02-14 3:03 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management LP | 1,650,000 6.300% | 450,000 (+37.50%) | Filing History |
| 2023-02-14 08:27 am Unchanged | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Capital LP | 1,816,531 6.610% | 0 (Unchanged) | Filing History |
| 2023-02-13 5:40 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 1,681,199 6.800% | 681,199 (+68.12%) | Filing History |
| 2023-01-10 12:48 pm Purchase | 2023-01-09 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 3,352,304 12.798% | 3,352,304 (New Position) | Filing History |